What is the role of telbivudine in the treatment of hepatitis B (HBV) (Hep B)?

Updated: Jun 08, 2021
  • Author: Nikolaos T Pyrsopoulos, MD, PhD, MBA, FACP, AGAF; Chief Editor: BS Anand, MD  more...
  • Print

Telbivudine, a cytosine nucleoside analogue, is a second-line agent (not preferred) used in HBV therapy. [19]  This drug is a potent inhibitor of HBV DNA polymerase. Although telbivudine appears to have slightly more potent antiviral activity than do adefovir and lamivudine, it is more expensive and plays a limited role in primary therapy.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!